Filter
546
Filtered Results: 546
Text search:
Global
Health
Institute,
University
of
California
Featured
Recommendations
57
New Publications
99
Language
Document type
No document type
232
Studies & Reports
150
Guidelines
81
Manuals
54
Strategic & Response Plan
11
Training Material
7
Fact sheets
4
Situation Updates
3
Resource Platforms
3
App
1
Countries / Regions
Global
37
Africa
10
Latin America and the Carribbean
9
Ghana
7
Congo, Democratic Republic of
7
South Africa
7
Brazil
7
India
7
Kenya
6
Ukraine
5
Western and Central Europe
5
Liberia
5
Sierra Leone
4
Asia
4
Tanzania
4
Uganda
4
Mexico
3
Syria
3
Zimbabwe
3
Guinea
3
Mozambique
3
USA
3
Eastern Europe
3
Russia
3
Namibia
3
Zambia
3
Nepal
2
Colombia
2
Thailand
2
Cameroon
2
Laos
2
Malawi
2
Guinea-Bissau
2
Germany
2
North America
2
Vietnam
2
Angola
2
Myanmar / Burma
2
North Macedonia
1
Tajikistan
1
El Salvador
1
Lesotho
1
China
1
Rwanda
1
Chile
1
Nigeria
1
Albania
1
Canada
1
Senegal
1
Kyrgyzstan
1
Afghanistan
1
Morocco
1
Philippines
1
Haiti
1
Cambodia
1
Venezuela
1
Hungary
1
Jordan
1
West and Central Africa
1
Jamaica
1
France
1
Norway
1
Portugal
1
Southern Africa
1
Argentina
1
Lebanon
1
Bangladesh
1
Yemen
1
Georgia
1
Mali
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
85
Countries
84
Public Health
42
Women & Child Health
37
Key Resources
23
Pharmacy & Technologies
8
Capacity Building
4
Toolboxes
HIV
80
Planetary Health
72
Mental Health
45
TB
43
COVID-19
38
NTDs
32
Global Health Education
25
Caregiver
16
Disability
15
NCDs
14
Rapid Response
11
Ebola & Marburg
11
Malaria
11
Health Financing Toolbox
9
Natural Hazards
8
AMR
6
Refugee
5
Social Ethics
5
Pharmacy
4
2.0 Rapid Response
4
Conflict
3
Zika
3
Polio
1
During the first two years of the project (2019–2020), through a ‘One Health’ approach, comprehensive engagement was established with AMR coordinating committees, WHO regional and country offices and SORT IT partners in Asia, Africa, Europe and the Americas. Thirty-seven research studies were ...
Updated 2 June 2022.#
This entry contains the Status Report of WHO Collaborating Centres in the Americas by Country and a new document with information of Collaborating Centres by Outcome of the Strategic Plan of the Pan American Health Organization 2020‑2025.
Trachoma is the leading infectious cause of blindness worldwide. In April 2023, it was a public health problem
in approximately 40 countries, with an estimated 116 million people at risk and 1.5 million people affected
by the late blinding stage of the disease (1). About 84% of those at risk of tr...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Guideline
Iron deficiency is one of the most common forms of nutritional deficiencies, particularly among vulnerable groups such as women, children and low-income populations. Iron deficiency often precedes anaemia, and anaemia during pregnancy is one of the strongest predictors of anaemia duri...
Iron deficiency is one of the most common forms of nutritional deficiencies, particularly among vulnerable groups such as women, children and low-income populations. Iron deficiency often precedes anaemia, and anaemia during pregnancy is one of the strongest predictors of anaemia duri...
Rreport of a WHO Consultative Meeting Kolkata India 2012
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The objectives of this guideline are the same as those of the 2011 edition, namely to provide evidence-based normative guidance on interventions to improve adolescent morbidity and mortality by reducing the chances of early pregnancy and its resulting poor health outcomes. The specific objectives of...
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment.
Undernutrition increases the risk of tuberculosis (TB) and in turn TB can lead to malnutrition. Undernutrition is therefore highly prevalent among people with TB. It has been demonstrated that undernutrition is a risk factor for progression from TB infection to active TB disease and that undernutrit...
Results from studies evaluating the effectiveness of focused psychosocial support interventions in children exposed to traumatic events in humanitarian settings in low-income and middle-income countries have been inconsistent, showing varying results by setting and subgroup (eg, age or gender). We a...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The annual bulletin of the Mekong Malaria Elimination (MME) programme is a yearly report that reviews ongoing efforts to combat multidrug resistance and eliminate malaria in the 6 countries of the Greater Mekong subregion (GMS): Cambodia, China (Yunnan province), Lao People's Democratic Republic, My...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl...
Climate change is increasing the risks of injuries, diseases, and deaths globally. However, the association between ambient temperature and renal diseases has not been fully characterized. This study aimed to quantify the risk and attributable burden for hospitalizations of renal diseases related to...
This is the first guidance note in a four-part series of notes produced by InterAction to support management,
program and M&E staff in international NGOs to plan, design, manage, conduct and use impact evaluations. This first guidance note, Introduction to Impact Evaluation, provides an overview of...
